11 Gestational Diabetes Mellitus Nursing Care Plans

Gestational diabetes mellitus (GDM) is glucose intolerance that shows up during pregnancy. In true GDM, glucose usually returns to normal by 6 weeks postpartum, but the risk does not clear with it: these women carry a higher lifetime risk of type 2 diabetes mellitus. During the pregnancy itself, the whole job is the balance between insulin and blood glucose, kept tight enough to prevent hyperglycemia and hypoglycemia and to protect a fetus that is drawing glucose around the clock. Uncontrolled glucose drives macrosomia, ketosis, placental problems, infection, and preterm labor, so the nursing work is daily and unglamorous: keep glucose in range, teach the patient to run her own glucometer, catch the swings early, and watch the fetus.

Nursing Care Plans and Management

The plan centers on glucose self-monitoring, insulin administration, achieving and maintaining normoglycemia, and ongoing evaluation of maternal and fetal wellbeing.

Nursing Problem Priorities

Monitor and manage blood glucose. Build a personalized meal plan that holds blood sugar steady. Teach self-monitoring and correct glucose-testing technique. Adjust insulin or other medication with the team as needs change. Track fetal growth with serial ultrasound and other tests. Promote physical activity within provider limits. Educate on the risks of GDM to mother and baby. Keep regular prenatal visits to monitor both.

Nursing Goals

Goals and expected outcomes may include:

• Within 4 hours, the patient verbalizes the treatment regimen and the need for regular glucose self-monitoring.
• Within 8 hours, the patient maintains fasting serum glucose 60-100 mg/dL and 1-hour postprandial no higher than 140 mg/dL, with no signs of diabetic ketoacidosis (fruity breath, excessive thirst, frequent urination, weakness, confusion).
• The patient gains 25-30 lbs prenatally, or as appropriate for prepregnancy weight.
• The patient follows the prescribed diet, stays free of hypoglycemia and hyperglycemia, and identifies the right food and fluid choices.
• The patient maintains vital signs and blood glucose within normal range.
• The patient demonstrates proficiency in self-monitoring and insulin administration and participates in managing diabetes during pregnancy.
• The patient stays free of infection and names interventions to reduce that risk.
• The fetus shows reactive nonstress tests with negative OCT and CST, is delivered full-term and vaginally without complications, and has normal weight and a normal blood glucose at birth.

Nursing Interventions and Actions

1. Managing Unstable Blood Glucose Levels

When insulin is insufficient, the cells cannot use glucose. They register the need, the liver converts stored glycogen, and serum glucose climbs higher because the glucose still cannot get into the cells. That is the loop you are trying to break.

Perform the prenatal screening test for GDM. For a woman without preexisting diabetes, screen routinely between 24 and 28 weeks gestation, earlier if risk factors are present. She drinks 50 g of oral glucose solution and a blood sample is drawn 1 hour later. A result of 130 to 140 mg/dL or higher sends her to the 3-hour glucose tolerance test.

Watch for hyperglycemia (confusion, increased thirst, frequent urination, visual changes) and hypoglycemia (dizziness, tremors, lethargy, sweating, pale cool moist skin). If she cannot raise her own insulin production, glucose accumulates and she runs high. Because the fetus continuously pulls glucose, she can also run low between meals and overnight.

Monitor vital signs, uterine contractions, and fetal heart rate (FHR). A rising FHR signals possible fetal distress; contractions can mark the start of preterm labor. Keep her informed of the early signs of labor.

Assess how stress affects her diabetes and teach stress management and relaxation. Stress hormones are counterregulatory: they raise glucose. Insulin sensitivity drops during stress (signaling defects downstream of the insulin receptor cut glucose transport in liver, muscle, and fat), while hepatic gluconeogenesis pushes glucose production up.

Teach and demonstrate fingerstick glucose monitoring. She will check several times a day as ordered, at home. She needs the technique and the meaning of the results, and she needs to fold them into her daily routine, which means ongoing supervision and support from the whole team. The closer to normal she keeps her glucose, the better the pregnancy outcome.

Provide the specifics of her diabetic management: human insulin only, switching from oral agents to insulin, and self-monitoring at least twice a day (before breakfast and before dinner). Metabolism and maternal-fetal needs shift across gestation. Insulin dose and frequency are tailored to the individual and often run on a sliding scale, where she varies the dose by each glucose reading. Two-thirds of the daily insulin is given before breakfast and one-third before dinner. She should eat immediately after injecting to avoid hypoglycemia.

Teach the difference between hyperglycemia and hypoglycemia, and bring family into the teaching. A patient on insulin will have episodes of both, so she has to recognize and respond to each.

Hypoglycemia hits most often in the first trimester, from the continuous fetal drain on glucose and amino acids and low human placental lactogen (HPL). Hypoglycemia is usually a glucose below 60 mg/dL. She may feel excessive hunger, trembling, weakness, faintness, lethargy, headache, irritability, sweating with pale cool moist skin, and even loss of consciousness.

Hyperglycemia comes from inadequate insulin, reduced activity, excess intake, and infection. A glucose above 120 mg/dL indicates hyperglycemia. Signs include fatigue; flushed hot skin; dry mouth; excessive thirst; dehydration; frequent urination; nausea and vomiting; rapid deep respirations; acetone breath (ketoacidosis); and depressed reflexes. To correct it, have her review her food intake honestly, so she does not adjust insulin against bad data.

Instruct her on treating symptomatic hypoglycemia. During a low, she drinks an 8 oz glass of milk or juice, or eats a piece of fruit or two crackers, then repeats in 15 minutes if glucose stays below 70 mg/dL. Simple carbohydrates raise glucose fast; following up with complex carbohydrate plus protein holds normoglycemia longer and steadies glucose through the day.

Discuss insulin type, dosage, and schedule. Dividing the dose covers basal needs and the mealtime insulin-to-food ratio and gives more freedom in meal timing. Total daily dose is based on gestational age, current weight, and glucose levels. Dose typically drops in the first trimester to avoid hypoglycemia, rises in the second as placental hormones increase insulin resistance, and may fall again at 38 weeks gestation. Insulin aspart and lispro are fast-acting and most effective given before meals.

Monitor fasting and 1-hour postprandial glucose on the first visit, then as her condition indicates. She should obtain fasting and 1-hour postprandial values four times a day, targeting fasting at 90 mg/dL and below and postprandial below 140 mg/dL. She documents the readings and brings them in so insulin or oral therapy can be adjusted.

Obtain glycosylated hemoglobin (HbA1c) every 2 to 4 weeks. HbA1c measures glucose bound to hemoglobin and reflects the average glucose over the past 4 to 6 weeks, not just the present value.

Administer IV fluids with insulin additives, or oral agents, as prescribed. Correcting glucose protects mother and fetus. Insulin is needed when diet or oral therapy cannot hold the line; short-acting insulin may run alone or with an intermediate type. Insulin pumps give strong glucose control and fewer hypoglycemic events.

Coordinate multispecialty care conferences. These let the team review both the pregnancy and the diabetes and plan for intrapartum and postpartum needs. A dietitian builds a workable diet, a diabetes management center can help, and neonatal nurses and a neonatologist are often present at birth.

Prepare for hospitalization if diabetes is uncontrolled. Infant morbidity tracks maternal hyperglycemia and the fetal hyperinsulinemia it drives. Continuous monitoring is needed to confirm that contractions and preterm birth have been halted.

2. Promoting Adequate Nutrition

Nutrition needs in GDM resemble a non-GDM pregnancy, but with a sharp focus on dietary modification to reach and hold maternal euglycemia. Readiness to change is high in pregnancy: perceived risk, motivation, and willingness to learn all rise, and nutrition is the bedrock of managing GDM.

Record dietary patterns and caloric intake with a 24-hour recall. This shows her understanding and adherence and lets you individualize advice around the habits she already has, good and bad.

Weigh her at every prenatal visit and have her track weight at home between visits. High prepregnancy BMI plus excessive gestational weight gain raises the risk of GDM, preeclampsia, large-for-gestational-age infants, and delivery complications. Lifestyle change (diet and exercise) cuts excessive gestational weight gain and the perinatal complications that follow.

Account for cultural factors. Identify what she considers normal eating and which patterns can be strengthened or changed. Carbohydrate-heavy staples (for example rice in South and Southeast Asian diets, with multiple carbohydrate sources in one meal) make restriction harder and need a realistic plan.

Teach the value of regular meals and snacks (three meals and four snacks) when on insulin. Frequent small meals improve insulin function. Spread a balanced intake across meals and at least three to four snacks to hold glucose steady. Adjust timing and content to prevent early-morning lows; favor slow-release foods; the bedtime snack matters for overnight hypoglycemia.

Use simple counseling tools. The T-shaped plate model controls portion size for main meals. Household measures (cups, glasses) make portions concrete. A food journal reviewed together shows how different foods move her glucose and where to adjust carbohydrate portions.

Teach proper carbohydrate restriction. Carbohydrate restriction is the most common medical nutrition approach in GDM and is recommended by ACOG and the Endocrine Society. A typical regimen is 1,800 to 2,400 calories, split into three meals and three snacks to spread carbohydrate evenly through the day. Aim for 20% of calories from protein, 40% to 50% from carbohydrate, and up to 30% from fat. Do not drop below 1,800 calories in pregnancy; intake that low in carbohydrate drives fat breakdown and acidosis.

Add fiber, cut saturated fat and cholesterol. Fiber blunts postprandial hyperglycemia and lowers insulin needs; saturated and total fat worsen insulin needs. Protein intake protects maternal stores from being broken down for fetal needs. Make her last snack of the day protein plus a complex carbohydrate (egg and whole-grain toast, or hummus and whole-grain crackers) for slow overnight digestion.

Adjust diet or insulin to fit the trimester. Needs change across gestation. Dose often drops in the first trimester when nausea cuts appetite and activity, rises in the second as placental hormones raise insulin resistance, and falls again at 38 weeks gestation.

Have her check urine ketones on waking and when a meal or snack is delayed. Ketonuria flags insufficient calories and a need for more carbohydrate or added snacks (for example, recurrent morning ketonuria may resolve with a glass of milk at 3 am). Ketonuria with hyperglycemia, though, demands prompt workup for diabetic ketoacidosis, which is rapidly fatal to the fetus.

Refer to a dietitian for an individualized plan and to answer dietary questions.

3. Promoting Safety and Preventing Injury

Starved of usable glucose, cells burn protein and fat, and ketones and acids build up. Estrogen, progesterone, placental insulinase, and rising prolactin all increase insulin resistance and breakdown, so glucose pools in the blood. That puts the mother at risk for hyperglycemia, gestational hypertension, cesarean birth, preterm labor, abruptio placentae, spontaneous abortion, and diabetic ketoacidosis.

Assess for placental abruption (vaginal bleeding, abdominal tenderness). Abruption, the premature detachment of the placenta after 20 weeks gestation, is a major driver of maternal and perinatal morbidity and mortality. Diabetic vascular changes that cause placental dysfunction raise that risk.

Assess for edema. Early insulin resistance and hyperinsulinemia drive renal sodium reabsorption and edema; vasoconstriction narrows small arteries and raises systolic pressure.

Check fundal height; assess for extremity edema and dyspnea. Polyhydramnios is a pathologic excess of amniotic fluid. With maternal hyperglycemia, fetal osmotic diuresis raises fetal urine output and amniotic fluid volume.

Watch for preterm labor; hydramnios can trigger early labor. She may present in preterm labor or with ruptured membranes, and excess fluid can produce a nonvertex presentation or cord prolapse. Severe polyhydramnios warrants delivery at a tertiary facility.

Note White's classification and the degree of diabetic control (Pedersen's criteria). White's classification, developed in 1949 and revised in 1980, estimates the risk of perinatal loss in diabetic pregnancies. Pedersen's criteria add four prognostically bad signs of pregnancy: clinical pyelonephritis; precoma and severe acidosis; toxemia; and maternal neglecters (late prenatal care, poor social circumstances).

Monitor vital signs, FHR, and contractions closely. A rising FHR signals fetal distress; contractions can mark preterm labor. Keep her and the provider informed of early labor signs.

Teach home glucose monitoring four times a day. She keeps glucose as close to normal as possible and learns the signs of hypoglycemia and hyperglycemia. Blood monitoring beats urine testing here, because pregnancy lowers the renal threshold for glucose and tighter control needs serum values.

Monitor urine ketones daily. Ketonuria can mean carbohydrate intake is too low and protein and fat are being burned. With hyperglycemia, it demands prompt workup for diabetic ketoacidosis, which can be rapidly fatal to the fetus.

Monitor closely if tocolytics are used to stop labor. Beta-agonist tocolytics stimulate sympathetic nerves and cause hyperglycemia. Atosiban, an oxytocin antagonist, raises cortisol and in turn raises glucose.

Check serum glucose each visit. Watch for hypoglycemia and ketoacidosis driven by the fetus's constant glucose use. She or the nurse should monitor regularly at home.

Monitor hematocrit and hemoglobin on the first visit, then in the second trimester and at term. First-visit hemoglobin is standard for gauging feto-maternal risk. Iron interferes with insulin action and impairs glucose entry into adipocytes, so body iron stores may play a role in GDM through their effect on insulin secretion and function.

Obtain HbA1c every 3 months. HbA1c reflects long-term (4 to 6 weeks) glucose control; lower is better. The normal upper level is 6% of total hemoglobin.

Monitor total protein excretion, creatinine clearance, BUN, and uric acid. Renal morbidity in GDM tracks with overt diabetes, and a rising serum creatinine can warn of silent kidney disease. A creatinine clearance test may be ordered each trimester; a normal rate means the vascular system, and by extension uterine perfusion, is intact.

Prepare her for ultrasonography at 28 and 36 to 38 weeks gestation. These scans assess fetal growth, amniotic fluid volume, placental location, and biparietal diameter. Oligohydramnios can mean growth restriction or a fetal renal abnormality; polyhydramnios can mean a GI malformation or poorly controlled disease.

Schedule an ophthalmologic exam in the first trimester for all patients, and each trimester for class D, E, or F. Background retinal changes (increased exudate, dot hemorrhage, macular edema) are common in diabetes and can progress or start in pregnancy. Laser coagulation therapy can help and reduce optic fibrosis.

Administer glucagon by IV infusion or subcutaneously for insulin shock. Glucagon comes as a dehydrated powder (Glucagon Emergency Kit) reconstituted with sterile water. Severe insulin shock or hypoglycemia is life-threatening, and glucagon is simple and safe to give.

Administer IV fluids and insulin for diabetic ketoacidosis (DKA). Fluid resuscitation and insulin are the mainstays. In DKA the fluid deficit can reach 10 to 15% of body weight, so immediate resuscitation is vital to correct hypovolemia, restore perfusion, and clear ketones. Continuous IV insulin is standard; in uncomplicated mild DKA, hourly subcutaneous insulin lispro may be safer and more cost-effective than regular IV insulin.

4. Preventing Macrosomia and Fetal Injury

Infants of poorly controlled diabetic mothers tend to be large (over 10 lb), because the extra insulin the fetus produces to handle the glucose overload acts as a growth stimulant. A macrosomic infant risks cephalopelvic disproportion and shoulder dystocia at delivery. Uncontrolled diabetes also raises the rates of congenital anomaly, spontaneous miscarriage, and stillbirth.

Determine White's classification and explain it to the patient or couple. The fetus is at less risk in class A, B, or C. A patient in class D, E, or F who develops kidney or acidotic problems or gestational hypertension is high risk. White's classification is used alongside evaluation of diabetic control and the presence of Pedersen's prognostically bad signs (acidosis, mild or severe toxemia, pyelonephritis).

Review her diabetic control before conception. Strict control (normal HbA1c) before conception cuts the risk of fetal death and congenital anomalies. Fasting hyperglycemia (over 105 mg/dL or 5.8 mmol/L) raises the risk of intrauterine fetal death in the last 4 to 8 weeks of gestation. GDM of any severity raises the risk of fetal macrosomia.

Assess for hypertensive disorders of pregnancy (edema, hypertension, proteinuria). About 12 to 13% of diabetic patients develop hypertensive disorders from the cardiovascular changes of diabetes. Hypertension is tied to significantly higher rates of small-for-gestational-age infants, preeclampsia, preterm delivery, and worse composite perinatal outcomes.

Assess fundal height each visit. Fundal height flags abnormal growth (macrosomia or IUGR, SGA or LGA). Hydramnios can develop when high glucose shifts fluid and enlarges amniotic volume. Macrosomia risks cephalopelvic disproportion at birth.

Assess fetal movement and FHR each visit; have her record fetal movements from about 18 weeks gestation, then daily from 34 weeks. Movement and FHR fall when placental insufficiency and maternal ketosis develop. She self-monitors by counting movements per hour (roughly ten fetal kicks). Make sure she knows activity varies with her own activity and meals, so normal variation does not frighten her.

Monitor her urine for ketones. Maternal ketonemia, especially in the third trimester, can cause irreparable CNS damage or fetal death. Urine ketone monitoring helps detect insufficient calories or carbohydrate in patients on calorie restriction.

Assess for fruity or acetone breath. That breath points to DKA, which can be rapidly fatal to the fetus. Early detection and treatment give good fetal outcomes.

Assess HbA1c every 4 to 6 weeks. The rate of congenitally malformed infants rises with high HbA1c (over 8.5%) early in pregnancy or before conception. HbA1c reflects long-term control but cannot guide daily insulin adjustment; it warns of fetal-anomaly risk.

Assess glycosylated albumin at 24 to 28 weeks gestation, especially in high-risk patients. Glycosylated albumin reflects glycemia over several days and avoids the glucose loading of an OGTT. It tracks postprandial hyperglycemia and glucose swings well and may reflect glycemic status more precisely.

Check creatinine clearance periodically. Renal vascular damage roughly parallels impaired uterine blood flow. A creatinine clearance test may be ordered each trimester; a normal rate means the vascular system, and uterine perfusion, is intact.

Educate her on how diabetes affects fetal growth and development. Understanding supports informed decisions and cooperation. The expectant mother may be anxious about herself and her child, and therapeutic communication lets her voice that.

Teach home glucose monitoring and diabetic management. ACOG targets fasting below 95 mg/dL (5.27 mmol/L), 1-hour postprandial below 130 to 140 mg/dL (7.22 to 7.77 mmol/L), and 2-hour postprandial below 120 mg/dL (6.66 mmol/L). Keeping mean glucose in that range lowers perinatal mortality, and postprandial testing is tied to fewer large-for-gestational-age infants, fewer cesarean births, and less neonatal hypoglycemia.

Explain the nonstress tests (NSTs). Fetal activity predicts wellbeing, and activity drops before FHR changes. Routine twice-weekly nonstress tests with an amniotic fluid index reduce stillbirth in pregnancies with pregestational diabetes or GDM.

Explain amniocentesis using the lecithin-sphingomyelin (L/S) ratio and the presence of phosphatidylglycerol (PG). An L/S ratio by amniocentesis, usually by week 36, assesses fetal lung maturity. In diabetic pregnancies the ratio tends to show maturity later, because hyperglycemia delays synthesis of phosphatidylglycerol, the compound that stabilizes surfactant. The presence of PG at amniocentesis is used to confirm lung maturity in these infants.

Monitor contractions and FHR during labor to catch placental dysfunction early.

Obtain alpha-fetoprotein (AFP) at 15 to 17 weeks gestation. Because diabetic mothers have higher rates of birth anomalies, a serum AFP at 15 to 17 weeks screens for neural tube defects.

Perform NST and oxytocin challenge test (OCT) or contraction stress test (CST) as appropriate. These assess fetal wellbeing and placental perfusion. Placental function may be checked by a weekly nonstress test or biophysical profile in the last trimester if she is in good control, or daily if control is poor. Higher-risk GDM mothers may begin twice-weekly nonstress tests and an amniotic fluid index between 32 and 36 weeks.

Prepare her for ultrasonography. Ultrasound confirms gestational dates and evaluates IUGR, macrosomia, and excess fluid. Many practitioners do third-trimester scans in all GDM patients to estimate fetal weight and identify cases where elective induction or cesarean may prevent birth complications.

Assist with the biophysical profile (BPP). The BPP scores NST results, fetal breathing, amniotic fluid volume, fetal tone, and body movement, with 2 points per criterion met. A total of 8 to 10 is reassuring, 4 to 7 needs further evaluation and retesting, and 0 to 3 is ominous. BPP twice a week can prevent fetal death in diabetic pregnancy.

Prepare for vaginal or surgical delivery if testing shows placental aging and insufficiency. For GDM well controlled on nutrition alone, ACOG advises against inducing before 39 weeks; expectant management to 40 6/7 weeks is reasonable with monitoring. For GDM requiring medication, deliver between 39 0/7 and 39 6/7 weeks. Before a scheduled cesarean or induction, cut the long-acting insulin dose by 50%, and hold insulin or oral agents the morning of surgery or induction. Maintain intrapartum control with a rotating fluid protocol: 5% dextrose in normal saline for maternal glucose below 100 mg/dL, lactated Ringer's or normal saline for glucose above 101 mg/dL, and a rapid-acting infusion for glucose above 140 mg/dL, titrated to a goal of 100 mg/dL.

5. Initiating Infection Control Measures and Preventing Infections

GDM raises the risk of genital-tract infection. Poor metabolic control, higher BMI, and impaired leukocyte function all contribute, and pregnancy itself is an immunocompromised state that increases vaginal Candida colonization. As insulin resistance climbs with gestational age, susceptibility rises with duration of pregnancy and poor glycemic control.

Assess for urinary tract infection (UTI). Watch for fever, flushed appearance, or cloudy urine. Catching a UTI early can prevent pyelonephritis, which can drive premature labor. Diabetes blunts T-cell and neutrophil function and disrupts humoral immunity.

Determine the nature of any vaginal discharge. With glycosuria, monilial vulvovaginitis from Candida albicans is more likely and can cause oral thrush in the newborn. Lactobacillus normally restrains candida; common complaints are abnormal discharge, itch, painful urination, and dyspareunia.

Inspect the feet for ulcers, infected ingrown toenails, or other problems. Foot injury, sensory neuropathy, and impaired circulation drive skin and soft-tissue infection in diabetics. Local signs include increased temperature, erythema, pain, loss of function, and edema.

Check vital signs, especially temperature. Local and systemic infection signs include fever, chills, tachycardia, hypotension, increased respiratory rate, fatigue, and metabolic disturbance. If treated as an outpatient, reassess in 2 to 4 days, or sooner if she worsens.

Promote handwashing by staff, patient, and family. Hand hygiene is the key strategy against healthcare-associated infections, since contaminated hands are the usual vehicle for cross-contamination.

Caution her against over-the-counter vaginal creams. Self-treatment can be wrong or mask infection. Self-medication carries real risks: drug interactions, polypharmacy, misdiagnosis, overdose, prolonged use, adverse events, dependence, and resistance. The FDA grades drugs from class A (safest) to class X (teratogenic), but only about 40% of drugs are classified, so few are confirmed safe in pregnancy.

Maintain aseptic technique for IV and catheter insertion. High blood glucose is an excellent medium for bacterial growth. Hyperglycemia raises pathogen virulence, lowers interleukin production in response to infection, and adds glycosuria and GI and urinary dysmotility.

Provide catheter and perineal care. Teach front-to-back cleaning to cut UTI risk. Candida likely reaches the vagina by migrating from the rectum across the perianal area. About 10% of reproductive-age women have recurrent infection, roughly 140 million worldwide.

Encourage adequate diet and fluids (at least 2,500 mL daily unless contraindicated). Fluids lower infection risk; increased urinary flow prevents stasis, keeps urine acidic, slows bacterial growth, and flushes organisms out.

Obtain urinalysis and urine culture. Asymptomatic bacteriuria is a positive culture without symptoms, and in pregnancy it always warrants treatment to reduce maternal and fetal risk. Group B Streptococcus carries a high risk of premature rupture of membranes and preterm labor and raises the risk of neonatal infection 25-fold.

Administer antibiotics as indicated. Antimicrobial therapy is the cornerstone for any bacterial infection, including UTI. Fosfomycin is acceptable in pregnancy. Treat asymptomatic bacteriuria with the standard 7-day regimen, except recurrent infection, which runs 10 to 14 days.

Obtain a culture of vaginal discharge if present. Candida vulvovaginitis can cause oral thrush in the newborn. Fungal cultures should be done in all pregnant patients to confirm candida.

Teach her to recognize infection. Early help avoids complications. Teach the common signs: fever, chills, tachycardia, hypotension, increased respiratory rate, fatigue, and, for wounds, increased temperature, erythema, pain, loss of function, and edema.

6. Enhancing Fluid Balance and Preventing Diabetic Ketoacidosis

Insulin requirements rise through pregnancy, which is why DKA is more common in the second and third trimesters. In DKA, hyperglycemia with glycosuria drives osmotic diuresis, the kidney's low threshold for ketoacids dumps them into the urine with electrolytes, and intravascular dehydration follows the large sodium loss with polyuria and polydipsia.

Assess and monitor vital signs. Hypovolemia shows as hypotension and tachycardia. The lungs blow off carbonic acid, producing a compensatory respiratory alkalosis, and acetone breath comes from acetoacetic acid breakdown. Correcting hyperglycemia and acidosis returns respirations toward normal. Fever with flushed dry skin can reflect dehydration.

Assess peripheral pulses, capillary refill, skin turgor, and mucous membranes. These gauge hydration and circulating volume. As she becomes volume-depleted, expect decreased urine output, dry mouth, poor capillary refill, poor turgor, and dry mucous membranes.

Weigh her daily. Weight is one of the best measures of fluid status and replacement adequacy. She may also report anorexia, nausea, vomiting, abdominal pain, and weight loss.

Monitor intake and output; note urine specific gravity. This estimates volume-replacement needs, kidney function, and therapy effectiveness. Hyperglycemia-driven diuresis, dehydration, hyperosmolarity, and electrolyte imbalance lower glomerular filtration, and worsening renal function worsens hyperosmolality.

Assess mentation and level of consciousness. Changes can come from high or low glucose, electrolyte abnormalities, decreased cerebral perfusion, acidosis, or hypoxia. Arterial pH is the prime determinant of mental status in DKA and acts synergistically with hyperosmolarity to depress consciousness.

Keep the environment comfortable. Cover her with light sheets to avoid overheating and further fluid loss. Fluid loss up to 1.4% of body weight is tolerated; at 3 to 6%, body productivity suffers.

Encourage fluids unless contraindicated. Diabetic pregnant women need more fluid from maternal physiologic change and fetal growth, and dehydration risk is high with insufficient intake. Endocrine changes in pregnancy affect water metabolism and balance.

Monitor hematocrit, BUN, creatinine, serum osmolality, sodium, and potassium. Hematocrit rises with hemoconcentration from osmotic diuresis. Elevated BUN and creatinine reflect cellular breakdown from dehydration. Serum osmolality rises with hyperglycemia and dehydration. Sodium falls as fluid shifts out of cells with osmotic diuresis. Potassium runs high at first in response to metabolic acidosis, but the total body potassium is depleted as it is lost in the urine.

Insert and maintain an indwelling catheter as indicated. A catheter gives accurate ongoing output measurement but should come out as soon as she is stable, to cut infection risk. Urinary catheters are the most common source of hospital infection and gram-negative bacteremia, and overlong catheterization with poor meatal asepsis is a predisposing factor.

Administer IV fluids as ordered. IV solutions replace intravascular and extravascular fluid, replenish electrolytes, and dilute glucose and counterregulatory hormones. Options include isotonic (0.9%) saline or lactated Ringer's.

Administer potassium and other electrolytes IV or orally as indicated. Add potassium to the IV as soon as urinary flow is adequate, to prevent hypokalemia. Amount and timing depend on the serum potassium, monitored closely, because volume expansion, resolving acidosis, and insulin all drive potassium back into cells and drop the serum level.

7. Promoting Adherence to Health Management

Near-normal glucose minimizes maternal and fetal complications, so both gestational and overt diabetics need more frequent prenatal visits for close monitoring. Several factors can undercut adherence and put mother and infant at risk, so the work here is partly clinical and partly building the relationship that makes the regimen stick.

Assess her knowledge of the disease and treatment. Basic understanding shows her why the regimen matters and how it leads to a safe delivery.

Assess her dietary plan. It should avoid sugar; limit fat, salt, and alcohol; and include complex high-fiber carbohydrate. Medical nutrition therapy lets her make choices around her own needs. For obese GDM patients, ACOG recommends reducing intake to roughly 24 kcal/kg per day in women over 120% of normal body weight.

Assess her knowledge of GDM complications. Awareness keeps her consistent and can delay complications. Cover acute and chronic ones (visual disturbance, neurosensory and cardiovascular change, renal impairment, hypertension, DKA) and the fetal and neonatal ones (macrosomia, congenital anomaly, birth injury, neonatal hypoglycemia).

Build trust through therapeutic communication. Rapport and respect come first; she has to feel heard before she will engage in learning.

Include her in building the care plan and learning goals. Participation drives cooperation, and motivation tracks closely with adherence.

Match the teaching strategy to her knowledge and learning capacity. Demonstrate skills with return demonstration, or fold new skills into routine. Mixed methods improve retention; guideline handouts alone do not change practice, so design teaching around her specific barriers.

Teach glucose self-monitoring with return demonstration. Walk her and the family through fingerstick testing, then have them demonstrate drawing the sample and running the glucometer until proficient. This runs four times a day; she documents the results and brings them to each checkup so the regimen can be adjusted.

Review her medication regimen. Identify her agents and confirm adherence. Combination drugs may hold more than one medication. Insulin dose and frequency are individualized and often run on a sliding scale tied to each glucose reading.

Teach insulin self-administration with return demonstration. Confirm her knowledge and correct any gaps. Have her draw up and inject, use the pen, or run a continuous pump. Followup observation and documentation are part of insulin administration.

Establish a regular exercise pattern. Exercise lowers glucose and, with diet, can reduce the need for insulin. Exercise after meals is preferred, since glucose is higher then. She checks glucose before, during, and after, and keeps hard candy on hand for hypoglycemia.

Teach the symptoms of hypoglycemia. Hunger, trembling, weakness, lethargy, irritability, headache, sweating with pale cool moist skin, blurred vision, or loss of consciousness. She and her family should recognize and manage it; lows often come from management errors that need early correction.

Teach the partner or family emergency glucagon. Glucagon treats severe hypoglycemia when she cannot take oral carbohydrate. A patient with decreased consciousness cannot safely swallow carbohydrate without aspiration risk, and IV access is hard in this population. A prefilled glucagon injection is approved, like an epinephrine autoinjector, and an intranasal powder spray is available for layperson use.

Stress the importance of followup care. Followup visits hold tighter control and can prevent flares and slow systemic complications. Antenatal care works; providers should be trained and supported to follow the guidelines for every pregnant patient.

Teach routine foot exam and foot care. Diabetes is the leading cause of nontraumatic lower-extremity amputation in the United States, and a foot ulcer usually follows poor glycemic control, neuropathy, or poor foot care. Show her how to examine the feet, check shoe fit, and care for toenails, calluses, and corns, and tell her never to go barefoot.

8. Initiating Patient Education and Health Teaching

Glucose monitoring, diet control, and frequent insulin can feel like a burden, especially without the rationale, and the expectant mother is often anxious about herself and her infant. Teach to understanding so she has the foundation to stay adherent.

Assess the patient's and couple's knowledge of the condition and treatment, including how diet, exercise, stress, illness, and insulin needs connect. Clear understanding supports informed decisions. Once GDM is diagnosed, the mainstays are medical nutrition, physical activity, weight management, and glucose monitoring. GDM is managed with lifestyle alone in up to 80 to 90% of patients.

Assess readiness to learn and individual learning needs. She may not be physically, emotionally, or mentally ready for new information, especially with competing stressors.

Assess factors affecting learning. Age, social and cultural influences, religion, life experience, education, and a sense of powerlessness all shape willingness to learn. Resolve language and physical barriers early. Communication, personal and environmental barriers, and quality of care are recurring problem areas for minority and low-income patients.

Teach home glucose monitoring and recording (at least 2 to 4 times a day). Self-monitoring starts at least four times daily: fasting and 1 to 2 hours postprandial. Targets are fasting glucose below 95 mg/dL, 1-hour postprandial below 140 mg/dL, and 2-hour postprandial below 120 mg/dL. For patients well controlled on diet alone, frequency may drop but should stay at least twice daily.

Explain normal versus abnormal weight gain and monitor weight, including home visits. Weight tracking confirms dietary adequacy and keeps gain within recommended rates. The Institute of Medicine recommends a pregnancy weight gain of 12.5 to 18 kg (27.5 to 39.6 lbs) for underweight women (BMI below 19.8 kg/m²), 11.5 to 16 kg (25.4 to 35.3 lbs) for healthy women (BMI 19.8 to 26.0 kg/m²), 7 to 11 kg (15.4 to 24.3 lbs) for overweight women (BMI 26.0 to 29.0 kg/m²), and at least 7 kg (15.4 lbs) for obese women (BMI above 29.0 kg/m²).

Explain the maternal and fetal effects of oral agents. Oral agents and insulin show comparable safety and efficacy overall, but metformin carries more risk of preterm birth and neonatal hypoglycemia than insulin, and glyburide, while similarly effective, raises the risk of macrosomia and neonatal hypoglycemia compared with insulin.

Teach the use and action of insulin and demonstrate administration (injection, nasal spray, or pump). Dose and frequency are individualized and often on a sliding scale tied to each reading. Dose typically drops in the first trimester to avoid hypoglycemia, rises in the second with increased insulin resistance, and may fall again at 38 weeks gestation. The insulin pump gives strong control and fewer hypoglycemic events.

Teach medical nutrition therapy (MNT) and appropriate intake. MNT aims for normal glycemic control without ketosis or fetal compromise and for adequate weight gain based on prenatal BMI. ACOG recommends reducing intake to roughly 24 kcal/kg per day in women over 120% of normal body weight.

Teach appropriate carbohydrate intake. She estimates the carbohydrate in each meal and doses insulin against a predetermined insulin-to-carbohydrate ratio. A typical plan is 1,800 to 2,400 calories (or 30 kcal/kg of ideal weight), split into three meals and three snacks to spread carbohydrate evenly through the day.

Teach prevention and treatment of hyperglycemia and hypoglycemia at home. Reduce saturated fat and cholesterol and increase fiber, which blunts postprandial hyperglycemia and lowers insulin needs. Make her last snack protein plus a complex carbohydrate (egg and whole-grain toast, or hummus and whole-grain crackers) for slow overnight digestion, when she is most vulnerable to lows.

Teach how to fold exercise into the regimen. Exercise lowers glucose and insulin needs; expect bigger glucose swings when she first starts. The effect lasts at least 12 hours after exercise. She eats a protein-plus-complex-carbohydrate snack before exercising and keeps the program consistent, for example 30 minutes of walking every day rather than hard effort one day and none the next.

Explain pregnancy's impact on the diabetes and what to expect. Knowledge cuts fear of the unknown and improves participation. Most women return to pregestational glycemic levels soon after delivery, though some continue with hyperglycemia, which may represent undiagnosed type 2 diabetes.

Explain the value of breastfeeding postpartum. Breastfeeding improves weight and glucose tolerance and reduces the risk of type 2 diabetes by about 14 to 15% yearly, with added metabolic benefits for the infant.

Teach the patient and family glucagon administration. Glucagon reliably raises glucose and relieves severe hypoglycemia long enough for definitive oral correction. The prefilled injection goes into the thigh; the intranasal powder needs no preparation and is sprayed into one nostril while the other is held closed.

Have her keep a diary of home glucose, insulin doses, reactions, general wellbeing, diet, and exercise. A diary lets the provider evaluate and adjust therapy. Persistent glucose intolerance is present in up to 20% of women at postpartum followup, and the later risk of type 2 diabetes is significantly increased.

9. Medications, Laboratory Monitoring, and Complication Surveillance

Insulin is the primary medication for GDM when lifestyle changes alone fall short. It is safe for mother and baby, and type, dose, and frequency are set by the provider against her glucose. Oral antidiabetic agents (metformin or glyburide) may be used when insulin is not feasible or is contraindicated; they lower glucose by improving insulin sensitivity or reducing hepatic glucose production and require careful monitoring.

Lab and diagnostic monitoring guides treatment. Self-monitoring of blood glucose (SMBG) gives real-time readings several times a day at home. HbA1c gives an average over the past 2 to 3 months for long-term control. The oral glucose tolerance test (OGTT) diagnoses GDM and may be repeated to track control. Urine testing for glucose and ketones flags uncontrolled glucose or ketosis. Fetal ultrasound and the nonstress test (NST) track fetal growth and wellbeing.

Surveillance catches complications early. On the maternal side, monitor blood pressure for gestational hypertension or preeclampsia, monitor weight for excessive gain that raises the risk of macrosomia or cesarean, and assess for excessive thirst, frequent urination, blurred vision, or signs of infection. On the fetal side, track fetal movement counts, assess growth by serial ultrasound for macrosomia or IUGR, and use the NST for fetal distress. Watch for hypoglycemia (sweating, shakiness, dizziness, confusion) in patients on insulin or oral agents, and test urine for proteinuria and ketones. Counsel her on the complications that matter (macrosomia, preterm birth, future type 2 diabetes) and on why self-care, diet, activity, and adherence drive the outcome.